Clinical Trials List
2022-01-05 - 2026-09-19
Phase III
Not yet recruiting1
Recruiting5
-
Trial Applicant
IQVIA RDS Taiwan Ltd.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2024/02/21
Investigators and Locations
Co-Principal Investigator
- Te-Chao Fang Division of Nephrology
- Yen-Chung Lin Division of Nephrology
- Li-Chun Hsieh Division of Radiology
- Shu-Ching Yeh Division of Nephrology
- Hsi-Hsien Chen Division of Nephrology
- 陳靜怡 Division of Nephrology
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- Cai-Mei Zheng Division of Nephrology
- Li-Yee Hong Division of Nephrology
- YUEH-HSUN LU Division of Radiology
- Mei-Yi Wu Division of Nephrology
- I-jen Chiu Division of Nephrology
- YUNG-HO HSU Division of Nephrology
- Chia-Te Liao Division of Nephrology
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chung-Yi Cheng Division of Nephrology
- Chung-Te Liu Division of Nephrology
- Chia-Hsun Lu Division of Radiology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 郭慧亮 Division of Nephrology
- Chiu-Ching Huang Division of Nephrology
- 陳永芳 Division of Radiology
- 陳怡儒 Division of Nephrology
- 洪毓權 Division of Nephrology
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
30 participants
-
Global
600 participants
